Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi

References (12)

1. Ghosh D, Bhattacharya B, Mukherjee B et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. Nutr Biochem 2002;13(11):690-697.
2. Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol 2004;42(6):1029-1042.
3. Anderson RA, Polansky MM, Bryden NA et al. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism 1983;32:894-899.
4. Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev 1999;57(11):329-335.
5. Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med 2003;33(3):213-230.
6. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus- a review. Diabetes Technol Ther 2006;8(6):677-687.
7. Lamson DS, Steven MP. The safety and efficacy of high-dose chromium. Altern Med Rev 2002;7(3):218- 235.
8. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology. 2002;180(1):5-22.
9. Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med 1990;152: 41-45.
10. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18:860-862.
11. Wasser WG, Feldman NS, DíAgati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410.
12. Cerulli J, Grabe DW, Gauthier I et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-431.